195 related articles for article (PubMed ID: 24961634)
1. PTEN and leukemia stem cells.
Fragoso R; Barata JT
Adv Biol Regul; 2014 Sep; 56():22-9. PubMed ID: 24961634
[TBL] [Abstract][Full Text] [Related]
2. PTEN in the haematopoietic system and its therapeutic indications.
Cheung AM; Mak TW
Trends Mol Med; 2006 Nov; 12(11):503-5. PubMed ID: 16996801
[TBL] [Abstract][Full Text] [Related]
3. PTEN expression and function in adult cancer stem cells and prospects for therapeutic targeting.
Ciuffreda L; Falcone I; Incani UC; Del Curatolo A; Conciatori F; Matteoni S; Vari S; Vaccaro V; Cognetti F; Milella M
Adv Biol Regul; 2014 Sep; 56():66-80. PubMed ID: 25088603
[TBL] [Abstract][Full Text] [Related]
4. Targeting the translational apparatus to improve leukemia therapy: roles of the PI3K/PTEN/Akt/mTOR pathway.
Martelli AM; Evangelisti C; Chappell W; Abrams SL; Bäsecke J; Stivala F; Donia M; Fagone P; Nicoletti F; Libra M; Ruvolo V; Ruvolo P; Kempf CR; Steelman LS; McCubrey JA
Leukemia; 2011 Jul; 25(7):1064-79. PubMed ID: 21436840
[TBL] [Abstract][Full Text] [Related]
5. Temporal changes in PTEN and mTORC2 regulation of hematopoietic stem cell self-renewal and leukemia suppression.
Magee JA; Ikenoue T; Nakada D; Lee JY; Guan KL; Morrison SJ
Cell Stem Cell; 2012 Sep; 11(3):415-28. PubMed ID: 22958933
[TBL] [Abstract][Full Text] [Related]
6. Hematopoietic and Leukemic Stem Cells Have Distinct Dependence on Tcf1 and Lef1 Transcription Factors.
Yu S; Li F; Xing S; Zhao T; Peng W; Xue HH
J Biol Chem; 2016 May; 291(21):11148-60. PubMed ID: 27044748
[TBL] [Abstract][Full Text] [Related]
7. Pten dependence distinguishes haematopoietic stem cells from leukaemia-initiating cells.
Yilmaz OH; Valdez R; Theisen BK; Guo W; Ferguson DO; Wu H; Morrison SJ
Nature; 2006 May; 441(7092):475-82. PubMed ID: 16598206
[TBL] [Abstract][Full Text] [Related]
8. [Molecular targeted therapy for leukemic stem cells].
Kikushige Y
Nihon Rinsho; 2015 May; 73(5):811-5. PubMed ID: 25985636
[TBL] [Abstract][Full Text] [Related]
9. PTEN in Regulating Hematopoiesis and Leukemogenesis.
Wu Y; Zhu H; Wu H
Cold Spring Harb Perspect Med; 2020 Oct; 10(10):. PubMed ID: 31712222
[No Abstract] [Full Text] [Related]
10. TIM-3 in normal and malignant hematopoiesis: Structure, function, and signaling pathways.
Kikushige Y
Cancer Sci; 2021 Sep; 112(9):3419-3426. PubMed ID: 34159709
[TBL] [Abstract][Full Text] [Related]
11. Regulation of hematopoietic and leukemic stem cells by the immune system.
Riether C; Schürch CM; Ochsenbein AF
Cell Death Differ; 2015 Feb; 22(2):187-98. PubMed ID: 24992931
[TBL] [Abstract][Full Text] [Related]
12. MicroRNAs as regulators in normal hematopoietic and leukemia stem cells: current concepts and clinical implications.
Fang K; Qian F; Chen YQ
Curr Mol Med; 2012 Jun; 12(5):536-46. PubMed ID: 22548295
[TBL] [Abstract][Full Text] [Related]
13. The PI-3kinase pathway in hematopoietic stem cells and leukemia-initiating cells: a mechanistic difference between normal and cancer stem cells.
Yilmaz OH; Morrison SJ
Blood Cells Mol Dis; 2008; 41(1):73-6. PubMed ID: 18387833
[TBL] [Abstract][Full Text] [Related]
14. [Progress in the leukemic stem cell study and a novel therapeutic approach targeting leukemic stem cells].
Kikushige Y; Miyamoto T; Akashi K
Rinsho Ketsueki; 2017; 58(10):1838-1843. PubMed ID: 28978822
[TBL] [Abstract][Full Text] [Related]
15. [New approaches to target leukemia stem cells].
Takenaka K; Akashi K
Nihon Rinsho; 2014 Jun; 72(6):1018-25. PubMed ID: 25016798
[TBL] [Abstract][Full Text] [Related]
16. Leukemia stem cells.
Buss EC; Ho AD
Int J Cancer; 2011 Nov; 129(10):2328-36. PubMed ID: 21796620
[TBL] [Abstract][Full Text] [Related]
17. Targeted elimination of leukemia stem cells; a new therapeutic approach in hemato-oncology.
ten Cate B; de Bruyn M; Wei Y; Bremer E; Helfrich W
Curr Drug Targets; 2010 Jan; 11(1):95-110. PubMed ID: 20017722
[TBL] [Abstract][Full Text] [Related]
18. Pten, tumorigenesis, and stem cell self-renewal.
Rossi DJ; Weissman IL
Cell; 2006 Apr; 125(2):229-31. PubMed ID: 16630811
[TBL] [Abstract][Full Text] [Related]
19. Hematopoietic Stem Cell Activity Is Regulated by Pten Phosphorylation Through a Niche-Dependent Mechanism.
Li J; Zhang J; Tang M; Xin J; Xu Y; Volk A; Hao C; Hu C; Sun J; Wei W; Cao Q; Breslin P; Zhang J
Stem Cells; 2016 Aug; 34(8):2130-44. PubMed ID: 27096933
[TBL] [Abstract][Full Text] [Related]
20. Recent progress on targeting leukemia stem cells.
Ma XY; Wei L; Lei Z; Chen Y; Ding Z; Chen ZS
Drug Discov Today; 2021 Aug; 26(8):1904-1913. PubMed ID: 34029689
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
